光子计数探测器对比增强乳腺计算机断层扫描:活体图像质量的初步经验及其与组织学的相关性
这项前瞻性研究纳入12例乳腺可疑病灶患者,采用光子计数探测器专用螺旋乳腺CT行对比增强扫描并辅以超声,15个病灶中14个恶性、1个为慢性炎症;所有病灶均呈明显对比剂摄取,信噪比119.7 ± 52.5,腺体组织与乳腺癌病灶间对比噪声比12.6 ± 5.9;浸润性肿瘤B-CT测值与组织学大小相关性显著且强(R = 0.77,P < 0.05),瘤周导管原位癌大小的相关性不显著(R = 0.80,P = 0.11)。
要点
- 对比增强B-CT上乳腺癌与周围腺体组织对比高,所有病灶均见明显对比剂摄取。
- 浸润性肿瘤B-CT测值与组织学大小相关性显著且强(R = 0.77,P < 0.05)。
- 瘤周导管原位癌B-CT测值与组织学大小相关性不显著(R = 0.80,P = 0.11)。
核心结论
- 对比增强B-CT在乳腺癌与周围腺体组织间显示高对比,作者认为其是颇具前景的癌灶检出与分期技术,可同时显示软组织病灶与微钙化,可能较乳腺MRI有实质性优势。
研究设计与样本
- 前瞻性研究,经当地伦理委员会批准,纳入12例经乳腺X线摄影或B-CT发现乳腺可疑病灶的女性,行对比增强螺旋B-CT及补充超声,全部病灶均获活检诊断及手术切除后组织学检查(含癌/导管原位癌大小)。
关键影像表现/征象
- 所有病灶均显示明显对比剂摄取,信噪比为119.7 ± 52.5。
- 腺体组织与乳腺癌病灶间对比噪声比为12.6 ± 5.9。
- 对比增强B-CT可同时显示软组织病灶与微钙化。
诊断标准与关键数值
- 浸润性肿瘤B-CT测值与传统组织学大小比较:R = 0.77(P < 0.05),相关性显著且强。
- 瘤周导管原位癌B-CT测值与组织学大小比较:R = 0.80(P = 0.11),相关性不显著。
临床应用与阅片要点
- 作者认为对比增强B-CT是颇具前景的癌灶检出与分期技术,可同时显示软组织病灶与微钙化,可能较乳腺MRI有实质性优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to investigate the feasibility, the image quality, and the correlation with histology of dedicated spiral breast computed tomography (B-CT) equipped with a photon-counting detector in patients with suspicious breast lesions after application of iodinated contrast media.
MATERIALS AND METHODS: The local ethics committee approved this prospective study. Twelve women with suspicious breast lesions found in mammography or B-CT underwent contrast-enhanced spiral B-CT and supplementary ultrasound. For all lesions, biopsy-proven diagnosis and histological workup after surgical resection were obtained including the size of cancer/ductal carcinoma in situ, which were correlated to sizes measured in B-CT. Signal-to-noise ratio and contrast-to-noise ratio were evaluated for tumor, glandular tissue, and fatty tissue.
RESULTS: Of the 12 patients, 15 suspicious lesions were found, 14 were malignant, and 1 benign lesion corresponded to a chronic inflammation. All lesions showed strong contrast media uptake with a signal-to-noise ratio of 119.7 ± 52.5 with a contrast-to-noise ratio between glandular tissue and breast cancer lesion of 12.6 ± 5.9. The correlation of the size of invasive tumors measured in B-CT compared with histological size was significant and strong R = 0.77 ( P < 0.05), whereas the correlation with the size of the peritumoral ductal carcinoma in situ was not significant R = 0.80 ( P = 0.11).
CONCLUSIONS: Contrast-enhanced B-CT shows high contrast between breast cancer and surrounding glandular tissue; therefore, it is a promising technique for cancer detection and staging depicting both soft tissue lesions and microcalcifications, which might be a substantial advantage over breast MRI.
引用
- Berger, Marcon, Wieler, et al. Contrast Media-Enhanced Breast Computed Tomography With a Photon-Counting Detector: Initial Experiences on In Vivo Image Quality and Correlation to Histology. Invest Radiol. 2022. PMID: 35220384. doi:10.1097/RLI.0000000000000863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。